New oral anticoagulants (NOACs), including direct thrombin inhibitors (DTIs) and factor Xa (FXa) inhibitors, are emerging alternatives for prophylaxis and treatment of atrialTreatment benefits compared with warfarin are small and vary depending on the control achieved by warfarin treatment....